. 2020 Apr 9;31(1):245–256. doi: 10.1007/s00062-020-00879-1

Table 2.

Motor performance in patients before and following surgery

Group	Presurgery	0–48 h postsurgery	3 months postsurgery
All patients (n = 71)	Intact: n = 66/71 Weak: n = 5/71	Intact: n = 56/68 Weak: n = 12/68	Intact: n = 64/68 Weak: n = 4/68
Tumor involving or displacing the peri-Rolandic cortex (n = 34)	Intact: n = 29/34 Weak: n = 5/34	Intact: n = 22/34 Weak: n = 12/34	Intact: n = 30/34 Weak: n = 4/34
Tumor not affecting M1 (n = 37)	Intact: n = 37/37 Weak: n = 0/37	Intact: n = 37/37 Weak: n = 0/37	Intact: n = 37/37 Weak: n = 0/37

Group

Presurgery

0–48 h postsurgery

3 months postsurgery

All patients (n = 71)

Intact: n = 66/71

Weak: n = 5/71

Intact: n = 56/68

Weak: n = 12/68

Intact: n = 64/68

Weak: n = 4/68

Tumor involving or displacing the peri-Rolandic cortex (n = 34)

Intact: n = 29/34

Weak: n = 5/34

Intact: n = 22/34

Weak: n = 12/34

Intact: n = 30/34

Weak: n = 4/34

Tumor not affecting M1 (n = 37)

Intact: n = 37/37

Weak: n = 0/37

Intact: n = 37/37

Weak: n = 0/37

Intact: n = 37/37

Weak: n = 0/37

Baseline and postsurgical muscle strength in brain tumor patients, scored using the Medical Research Council scale. Intact performance (score 5/5) and weakness (score 0–4) were rated for upper and lower limbs prior to surgery, immediately postsurgery and at clinical follow-up (3 months after surgery)